Purpose To determine whether the amount of fluorine-18 fluorodeoxyglucose (FDG) uptake
in the primary lung cancer on positron emission tomography (PET) imaging at the time of …

Introduction The intensity of 18 F-fluorodeoxyglucose (18 F-FDG) uptake in positron
emission tomography could be of prognostic significance for patients with non-small cell …

Purpose To determine whether the standardized uptake value (SUV) of [18F]
fluorodeoxyglucose uptake by positron emission tomography could be a prognostic factor for …

Objective: To determine if the intensity of fluorine-18-fluorodeoxyglucose (FDG) uptake in
primary non-small cell lung cancer (NSCLC) could independently predict patient prognosis …

Purpose: This prospective study evaluated the prognostic significance of 18F-
fluorodeoxyglucose (18F-FDG) uptake in primary non-small cell lung cancer (NSCLC) at …

The aim of this study was to determine whether quantitative information obtained from [18 F]
fluorodeoxyglucose positron emission tomography (18 F-FDG PET) has a prognostic …

PURPOSE: The amount of radio-labeled 18F-fluoro-2-deoxy-glucose (FDG) uptake, a
measurement of the increased glucose metabolism of non–small-cell lung cancer (NSCLC) …

Purpose: Because the tumor stage is the most significant prognostic factor for non-small cell
lung cancer (NSCLC) and given that NSCLC [18F] fluorodeoxyglucose (18F-FDG) uptake …

PURPOSE: To prospectively study the impact of 18F fluorodeoxyglucose (FDG) positron
emission tomography (PET) on clinical management of patients with non–small-cell lung …

Background 18 F-fluorodeoxyglucose (FDG) uptake holds potential as a noninvasive
biomarker in patients with non-small cell lung cancer (NSCLC). We aimed to investigate the …